Introduction to Refractory Ulcerative
Sentence Examples
Discover more insights into Refractory Ulcerative
Keywords frequently search together with Refractory Ulcerative
Narrow sentence examples with built-in keyword filters
Refractory Ulcerative sentence examples within ileal pouch anal
A 30-year-old man with a history of medically refractory ulcerative colitis (UC) and primary sclerosing cholangitis (PSC) for which he underwent three-stage total proctocolectomy (TPC) with ileal pouch anal anastomosis (IPAA) was evaluated for complaints of frequency, urgency of bowel movements, abdominal pain, and joint pain.
Full Text
Pouchitis is the most common long-term complication in patients requiring colectomy ileal pouch-anal anastomosis with medically refractory ulcerative colitis or colitis-associated neoplasia.
Full Text
Refractory Ulcerative sentence examples within year old female
In this video vignette, we present the case of a 21-year old female with medically refractory ulcerative colitis who previously underwent subtotal colectomy with an end ileostomy.
Full Text
This is a clinical case report of a 52-year-old female patient with 30 years history of left-sided chronic ulcerative colitis controlled with standard of care (mesalamine and azathioprine) which subsequently relapsed and developed into active refractory ulcerative colitis.
Full Text
Refractory Ulcerative sentence examples within Medically Refractory Ulcerative
A 30-year-old man with a history of medically refractory ulcerative colitis (UC) and primary sclerosing cholangitis (PSC) for which he underwent three-stage total proctocolectomy (TPC) with ileal pouch anal anastomosis (IPAA) was evaluated for complaints of frequency, urgency of bowel movements, abdominal pain, and joint pain.
Full Text
Pouchitis is the most common long-term complication in patients requiring colectomy ileal pouch-anal anastomosis with medically refractory ulcerative colitis or colitis-associated neoplasia.
Full Text
Learn more from Refractory Ulcerative
Refractory Ulcerative sentence examples within Treatment Refractory Ulcerative
Refractory Ulcerative sentence examples within Chronic Refractory Ulcerative
Refractory Ulcerative sentence examples within refractory ulcerative colitis
We have written on the off-label use of subcutaneous golimumab, which helped to induce and maintain remission on a low-weight biologically experienced child with steroid-refractory ulcerative colitis flare.
Full Text
A 30-year-old man with a history of medically refractory ulcerative colitis (UC) and primary sclerosing cholangitis (PSC) for which he underwent three-stage total proctocolectomy (TPC) with ileal pouch anal anastomosis (IPAA) was evaluated for complaints of frequency, urgency of bowel movements, abdominal pain, and joint pain.
Full Text
Refractory Ulcerative sentence examples within refractory ulcerative proctitis
Thirteen therapy-refractory ulcerative proctitis patients were endoscopically injected bone marrow-derived allogeneic MSCs from healthy donors.
Full Text
Background Mesalazine-refractory ulcerative proctitis is common, with a significant proportion of the patients requiring escalation to immunomodulators or biological therapy.
Full Text
We have written on the off-label use of subcutaneous golimumab, which helped to induce and maintain remission on a low-weight biologically experienced child with steroid-refractory ulcerative colitis flare.
Full Text
BACKGROUND
We evaluated whether integration of novel diets for donors and patients in addition to fecal transplantation (FT) could increase FT remission rate in refractory ulcerative colitis (UC).
Full Text
We report a 60-year-old male who was transferred to our hospital for the operation because of refractory ulcerative colitis (UC).
Full Text
Medical rescue therapy for patients with severe steroid-refractory ulcerative colitis (UC) consists of intravenous (IV) cyclosporine or infliximab and remains limited.
Full Text
A multicenter clinical trial is currently underway in Japan for patients with refractory ulcerative colitis and Crohn’s disease.
Full Text
In this real-world cohort study that included patients with refractory ulcerative colitis to multiple therapies, more than one-half of patients were still treated by ustekinumab and one-third were in steroid-free clinical remission, after 52 weeks.
Full Text
However, the treatment of patients with severe steroid-refractory ulcerative colitis remains a serious challenge to clinicians.
Full Text
We evaluated if integration of novel diets for donors and patients in addition to fecal transplantation (FT) could increase FT remission in refractory ulcerative colitis (UC) or have an independent effect on remission.
Full Text
Tacrolimus (Tac) is an effective remission inducer of refractory ulcerative colitis (UC).
Full Text
Background: Infliximab (IFX) and calcineurin inhibitors (cyclosporine [CYS] and tacrolimus [TAC]) were considered as rescue therapy in steroid-refractory ulcerative colitis (UC).
Full Text
Thirteen therapy-refractory ulcerative proctitis patients were endoscopically injected bone marrow-derived allogeneic MSCs from healthy donors.
Full Text
Background The immunomodulatory and antiangiogenic effects of thalidomide have been demonstrated in a number of refractory ulcerative oromucosal conditions, including recurrent aphthous stomatitis (RAS), Behcet disease, erythema multiforme (EM), erosive lichen planus, and orofacial granulomatosis (OFG).
Full Text
Background/Aims
Infliximab (IFX) has been used to induce and maintain remission in patients with severe steroid-refractory ulcerative colitis (UC).
Full Text
BACKGROUND
Anti-tumour necrosis factor (TNF) agents are the mainstay of long-term treatment for refractory ulcerative colitis.
Full Text
Lack of efficacy, infusion reaction and drug eruption: 21 case reports In a retrospective study involving 123 patients with refractory ulcerative colitis (UC) treated between July 2010 and August 2018 across various hospitals in Japan, 21 patients [ages and sexes not stated] were described who exhibited lack of efficacy (18 patients), developed infusion reactions (2 patients) or developed eruption (1 patient) during treatment with adalimumab, golimumab or infliximab [durations of treatments to reactions onsets and outcomes not stated].
Full Text
BACKGROUND It is a crucial issue for patients with refractory ulcerative colitis (UC), including steroid-dependent and steroid-refractory patients, to achieve and maintain steroid-free remission.
Full Text
Background and Aims
The objective of this study was to examine the modulating effect of an appendectomy on the disease course of therapy-refractory ulcerative colitis [UC] patients, and to analyse appendiceal pathological characteristics predictive of pathological response.
Full Text
To assess the effectiveness and safety of combining granulocyte‐monocyte apheresis (GMA) and vedolizumab (VDZ) in patients with refractory ulcerative colitis (UC).
Full Text
Between February 2017 and June 2018 eight patients with steroid-refractory ulcerative colitis given ciclosporin and infliximab therapy in succession were identified.
Full Text
Editor We thank Herfarth and Barnes for their valuable comment and justified questions regarding our paper analysing the effect of appendicectomy in patients with refractory ulcerative colitis (UC)1.
Full Text
Editor We thank Dai and Jiang for their interesting comment regarding our paper analysing the effect of appendicectomy in patients with refractory ulcerative colitis (UC)1.
Full Text
This study aimed to analyse the effect of appendicectomy in patients with refractory ulcerative colitis.
Full Text
Fifty patients with refractory ulcerative colitis were randomly distributed to either group I (n = 25): on adalimumab injection (160/80 mg) or group II (n = 25): on infliximab injection (5 mg/kg) along the term of induction.
Full Text
Here, we describe the use of combination oral antibiotics as salvage therapy in refractory ulcerative colitis (UC), Crohn's colitis, and IBD-unclassified (IBD-U) at a large pediatric IBD center.
Full Text
We describe a patient with chronic cholestasis and loss of intrahepatic bile ducts after therapy with infliximab for refractory ulcerative colitis consistent with a diagnosis of vanishing bile duct syndrome.
Full Text
Case presentationWe present the case of a 14-year-old Caucasian boy with refractory ulcerative colitis, admitted to the Child Neuropsychiatry Unit of the Polyclinic Hospital of Bari in the course of his first-episode psychosis.
Full Text
Background
Infliximab pharmacokinetics in steroid-refractory ulcerative colitis (UC) suggest a need for higher dosing, but data concerning efficacy of intensification in this setting are lacking in children and inconsistent overall.
Full Text
Background and ObjectivesTacrolimus is very effective at inducing remission in patients with refractory ulcerative colitis.
Full Text
Background Mesalazine-refractory ulcerative proctitis is common, with a significant proportion of the patients requiring escalation to immunomodulators or biological therapy.
Full Text
’s study on appendicectomy for the treatment of therapy-refractory ulcerative colitis,1 which received over 10 000 impressions.
Full Text
Background Although methotrexate (MTX) is used for refractory ulcerative colitis (UC) in clinical practice, there is still controversy about whether MTX is as effective in UC as that in Crohn’s disease (CD).
Full Text
Background/Aims Tacrolimus is effective for refractory ulcerative colitis in adults, while data for children is sparse.
Full Text
We herein report a case in which PAH developed in a patient with refractory ulcerative colitis during treatment with “Qing-Dai,” a Chinese herbal medicine.
Full Text
A 40-year-old man with refractory ulcerative colitis (UC) was treated with tumor necrosis factor α inhibitor (anti-TNFα), infliximab.
Full Text
Tacrolimus (TAC) is an important therapeutic option for remission induction in patients with refractory ulcerative colitis (UC).
Full Text
Tacrolimus is a calcineurin inhibitor that has recently been used in the treatment of steroid-refractory ulcerative colitis.
Full Text